86 related articles for article (PubMed ID: 29463415)
1. Endocrinology of prostate cancer.
Claessens F; Visakorpi T
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):1-2. PubMed ID: 29463415
[No Abstract] [Full Text] [Related]
2. Small non-coding RNAs in endocrinology.
Lalli E
Mol Cell Endocrinol; 2017 Nov; 456():1. PubMed ID: 28888232
[No Abstract] [Full Text] [Related]
3. The genomic landscape of prostate cancer.
Spans L; Clinckemalie L; Helsen C; Vanderschueren D; Boonen S; Lerut E; Joniau S; Claessens F
Int J Mol Sci; 2013 May; 14(6):10822-51. PubMed ID: 23708091
[TBL] [Abstract][Full Text] [Related]
4. Prediction efficiency of PITX2 DNA methylation for prostate cancer survival.
Luan ZM; Zhang H; Qu XL
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173224
[TBL] [Abstract][Full Text] [Related]
5. [The latest research of the molecular biomarker in prostate cancer].
Ashikari D; Takahashi S
Nihon Rinsho; 2016 Jan; 74(1):50-4. PubMed ID: 26793879
[TBL] [Abstract][Full Text] [Related]
6. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
7. The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition.
Kmeťová Sivoňová M; Jurečeková J; Tatarková Z; Kaplán P; Lichardusová L; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):487-499. PubMed ID: 29372682
[TBL] [Abstract][Full Text] [Related]
8. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of EphA5 by promoter methylation in human prostate cancer.
Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
[TBL] [Abstract][Full Text] [Related]
10. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
[TBL] [Abstract][Full Text] [Related]
11. GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
Martignano F; Gurioli G; Salvi S; Calistri D; Costantini M; Gunelli R; De Giorgi U; Foca F; Casadio V
Dis Markers; 2016; 2016():4358292. PubMed ID: 27594734
[TBL] [Abstract][Full Text] [Related]
12. DNA methylome and the complexity of discovering prostate cancer biomarkers.
Koochekpour S
Asian J Androl; 2011 Sep; 13(5):661-2. PubMed ID: 21725333
[No Abstract] [Full Text] [Related]
13. Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
Carozzi F; Tamburrino L; Bisanzi S; Marchiani S; Paglierani M; Di Lollo S; Crocetti E; Buzzoni C; Burroni E; Greco L; Baldi E; Sani C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):201-12. PubMed ID: 26210155
[TBL] [Abstract][Full Text] [Related]
14. [microRNA].
Kojima S; Seki N
Nihon Rinsho; 2016 May; 74 Suppl 3():201-4. PubMed ID: 27344729
[No Abstract] [Full Text] [Related]
15. Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer.
Liu JW; Nagpal JK; Jeronimo C; Lee JE; Henrique R; Kim MS; Ostrow KL; Yamashita K; van Criekinge V; Wu G; Moon CS; Trink B; Sidransky D
Prostate; 2008 Mar; 68(4):418-26. PubMed ID: 18196513
[TBL] [Abstract][Full Text] [Related]
16. Endocrinology and the prostate. Preface.
Labrie F
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):vii-ix. PubMed ID: 18471779
[No Abstract] [Full Text] [Related]
17. Molecular changes associated with prostate cancer development.
Ruijter E; Montironi R; van de Kaa C; Schalken J
Anal Quant Cytol Histol; 2001 Feb; 23(1):67-88. PubMed ID: 11233745
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs in human cancer: one step forward in diagnosis and treatment.
Li C; Zhang L
Brief Funct Genomics; 2016 May; 15(3):165-6. PubMed ID: 27226104
[No Abstract] [Full Text] [Related]
19. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor-mediated transcription.
Kurisu T; Tanaka T; Ishii J; Matsumura K; Sugimura K; Nakatani T; Kawashima H
Prostate Cancer Prostatic Dis; 2006; 9(2):173-8. PubMed ID: 16607388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
